Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Mark J. Litton Net Worth & Insider Trades

Mark J. Litton - Chief Business Officer, Alder Biopharmaceuticals Inc

As of June 5, 2018

What is Mark J. Litton's Net Worth?

The current estimated net worth of Alder Biopharmaceuticals Inc's Chief Business Officer, Mark J. Litton, is estimated to be about $6.06M . Mark J. Litton owns about 128,189 units of Alder Biopharmaceuticals Inc common stock. In the last 3 years at Alder Biopharmaceuticals Inc, Mark J. Litton has sold an estimated value of $5.07M worth.

What is Mark J. Litton's Past Insider Trading?

Mark J. Litton's largest purchase order was 16,520 units , worth over $27.26K on October 18, 2017. Mark J. Litton's largest sale order was 25,000 units , worth over $1.11M on June 8, 2015. In total, Mark J. Litton has made about 19 transactions over 3 years of their time at Alder Biopharmaceuticals Inc. Mark J. Litton usually trades in January, with the busiest year in 2015 and 2016. The most recent transaction was a sale order of 22,727 units , worth over $405.41K on June 5, 2018.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Mark J. Litton

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Mark J. Litton's' Mailing Address?

  • Mailing address is 11804 North Creek Parkway South Bothell WA 98011 WA

What are Alder Biopharmaceuticals Inc's Past Insider Trades?

Alder Biopharmaceuticals Inc's most recent insider trade came on October 24, 2019 by H. Lundbeck A/s Deborah Dunsire, Name: Deborah Dunsire, Title: Chief Executive Officer who bought 85,923,561 units worth $0 . In the last 4 years, insiders at Alder Biopharmaceuticals Inc have sold an estimated value of $106.61M and bought an estimated value of $22.34M worth of shares. Insider trading is most common in May, with the busiest year in 2015. The most active traders at the company are Jeffrey Smith, Managing Director,  John Latham, Chief Scientific Officer,  and Mark J. Litton, Chief Business Officer .

ALDER BIOPHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...